Drug Shortage Report for ELAVIL
Report ID | 147843 |
Drug Identification Number | 00335061 |
Brand name | ELAVIL |
Common or Proper name | Elavil |
Company Name | AA PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | AMITRIPTYLINE HYDROCHLORIDE |
Strength(s) | 25MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100BTL |
ATC code | N06AA |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2021-10-22 |
Actual start date | |
Estimated end date | |
Actual end date | 2022-05-06 |
Shortage status | Resolved |
Updated date | 2022-05-07 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2022-05-07 | English | Compare |
v5 | 2022-05-06 | French | Compare |
v4 | 2022-05-06 | English | Compare |
v3 | 2021-10-23 | English | Compare |
v2 | 2021-10-22 | French | Compare |
v1 | 2021-10-22 | English | Compare |
Showing 1 to 6 of 6